Research in Mayo Clinic's Liver Disease Immunobiology Lab led by Petra Hirsova, Pharm.D., Ph.D., focuses on metabolic dysfunction-associated steatohepatitis.

Multi-modal data integration of single-nuclei RNA and ATAC sequencing with spatial transcriptomics, provides new molecular insights into gene regulatory networks driving cell state transitions in ...

Expands Development Portfolio with Introduction of a Novel Program Targeting PSC – – Confirms Highly Specific Allosteric ACLY Inhibitor Shown to Reduce Liver Injury, Inflammation and Fibrosis Across ...

Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.

Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.

Researchers have revealed a temporal disruption in the metabolism of obese mice when adapting to starvation despite no significant structural disruptions in the molecular network. This is a ...

Two international academic journals have found that it is effective to apply classical treatments to patients with advanced ...

Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that ...

Experts have said that initially screenings are done with the lipid profile, random blood sugar and ultrasound abdomen ...

World Liver Day began in 2010 due to the increased number of liver diseases among people. It was an initiative by the European Association for the Study of the Liver (EASL) to seek people’s attention ...